The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Clinical trial NCT06458257 · RECRUITING
Trial details
- NCT number
- NCT06458257
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-19
- Primary completion
- 2026-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.